Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04046146 · ClinicalTrials.gov registry record · Phase 1
Near InfraRed Fluorescence Using Indocyanine Green and Magnetic Resonance Lymphography of Lymphatic Transport
A Phase 1 study, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 1
- Development phase
- 2
- Enrollment target
NCT04046146 is a Phase 1 study that has completed, run by University of Rochester. The registered enrollment target is 2 participants.
The verdict
NCT04046146, a Phase 1 study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
Lymphatic transport will be examined using Near InfraRed Indocyanine Green fluorescence imaging (NIR-ICG) and magnetic resonance lymphography (MRL) of the upper extremities. The purpose of the study is to establish if NIR-ICG is a valid clinical outcome for quantifying lymphatic vessel drainage.
Interventions
- DRUG Indocyanine Green
- DEVICE MultiSpectral Imaging System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2019-12-15 |
| Est. Completion | 2020-03-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04046146
The ClinicalTrials.gov registry entry for NCT04046146 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Indocyanine Green is the first listed.
NCT04046146 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04046146 about?
NCT04046146 is a clinical study titled "Near InfraRed Fluorescence Using Indocyanine Green and Magnetic Resonance Lymphography of Lymphatic Transport". Lymphatic transport will be examined using Near InfraRed Indocyanine Green fluorescence imaging (NIR-ICG) and magnetic resonance lymphography (MRL) of the upper extremities. The purpose of the study is to establish if NIR-ICG is a valid clinical outcome for quantifying lymphatic vessel drainage.
What is the current status of trial NCT04046146?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2019-12-15. Estimated completion is 2020-03-15.
What interventions are being tested in trial NCT04046146?
The interventions under investigation include: Indocyanine Green (DRUG), MultiSpectral Imaging System (DEVICE).
Who is sponsoring clinical trial NCT04046146?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.